Barriers and missed opportunities to HIV testing among injection drug users in two Mexico-US border cities

Drug and Alcohol Review

Volumn 27, Issue 1, 2008, Pages 39-45

  Moyer, Laura B ^a,b   Brouwer, Kimberley C ^a   Brodine, Stephanie K ^b   Ramos, Rebeca ^c,d   Lozada, Remedios ^e   Cruz, Michelle Firestone ^a   Magis Rodriguez, Carlos ^f   Strathdee, Steffanie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c United States Mexico Border Health Association   (United States)

^d Programa Compañeros and Compañeros International   (Mexico)

^e Patronato Pro COMUSIDA   (Mexico)

^f SECRETARÍA DE SALUD   (Mexico)

Author keywords

Barriers; HIV; Injection drug use; Mexico; Testing

Indexed keywords

EID: 36549035659     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701710845     Document Type: Article

References (36)

1. UNAIDS AIDS Epidemic Update. Joint United Nations Programme on HIV/AIDS. Geneva: UNAIDS and World Health Organisation (WHO), December 2004. Available at: www.unaids.org/wad2004/report_pdf.html (accessed 12 February 2006).
2. Coronado R, Vargas L. Economic update on El Paso del Norte. El Paso Business Frontier 2001;2:1-5.
3. Secretaria de Salubridad y Asistencia (SSA). Encuesta nacional de adicciones 1998. Available at: www.salud.gob.mx/unidades/conadic/epidem.htm (accessed 16 November 2005).
4. Brouwer KC, Case P, Ramos R, et al. Trends in production, trafficking and consumption of methamphetamine and cocaine in Mexico. Subst Abuse Misuse 2006;41:707-27.
5. US Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 National Survey on Drug Use and Health: national findings 2004. Rockville, MD: SAMHSA.
6. Bucardo J, Brouwer KC, Magis-Rodriguez C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood-borne infections. Drug Alcohol Depend 2005;79: 281-93.
7. Magis-Rodríguez C, Brouwer KC, Morales S, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican - U.S. border city of Tijuana. J Psychoact Drugs 2005;37:333-9.
8. Brouwer KC, Strathdee SA, Magis-Rodríguez C, et al. Estimated numbers of men and women infected with HIV/ AIDS in Tijuana, Mexico. J Urban Health 2006;83:299-307.
9. UNAIDS AIDS epidemic update. Joint United Nations Programme on HIV/AIDS. Geneva: UNAIDS and World Health Organization (WHO), December 2005. Available at: www.unaids.org/wad2005/report_pdf.html (accessed 15 January 2006).
10. Deany P. HIV and injecting drug use: a new challenge to sustainable human development 2000. Available at: http:// www.undp.org/hiv/publications/deany.htm (accessed 29 March 2007).
11. Viani RM, Araneta MR, Ruiz-Calderon J, et al. Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection. J Acquire Immune Defic Syndr 2006;41:87-92.
12. South County Economic Development Council. San Diego/ Tijuana border value, 2002. Available at: www. sandiegosouth.com (accessed 29 March 2007).
13. US Department of Transportation. Bureau of Transportation statistics, special tabulation, June 2001. Available at: http:// www.bts.gov/publications/ north_american_trade_and_travel_trends/tables/table_12.html (accessed 29 March 2007).
14. Instituto Nacional de Estadistica Geografia e Informatica. XII Censo General de Población y Vivienda 2000. Available at: http://www.inegi.gob. mx/inegi/default.aspx (accessed 29 March 2007).
15. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle H, De Cock K. The serostatus approach to fighting the HIV epidemic. Am J Public Health 2001;91:1019-24.
16. Alwano-Edyegu MG, Marum E. Knowledge is power: voluntary HIV counseling and testing in Uganda 1999. Geneva: UNAIDS.
17. Schlumberger MG, Desenclos J, Papaevangelou G, Richardson S, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. Eur J Epidemiol 1999;15:207-15.
18. Van Ameijden EJ, van den Hoek AR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994;84:275-81.
19. Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Problems 1997;44:174-99.
20. White EF, Garfein RS, Brouwer KC, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica de Mexico 2007;49:165-72.
21. Massey DS, Arango J, Hugo G, Kouaouci A, Pellegrino A. An evaluation of international migration theory: the North American case. Popul Dev Rev 1994;20:699-751.
22. Brockerhoff M, Biddlecom AE. Migration, sexual behavior and the risk of HIV in Kenya. Int Mig Rev 1999;33:836-56.
23. Peterson W. A general typology of migration. Am Sociol Rev 1958;23:256-65.
24. Rachlis B, Brouwer KC, Mills EJ, Hayes M, Hogg RS. Migration of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend 2007;90:107-19.
25. Blankenship K, Bray S, Merson M. Structural interventions in public health. AIDS 2000;14:11-21.
26. Liddicoat R, Horton N, Urban R, Maier E, Christiansen D, Samet J. Assessing missed opportunities for HIV testing in medical settings. J Gen Int Med 2004;19:349-56.
27. Desai AA, Latta ET, Spaulding A, Rich JD, Flanigan TP. The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev 2002;14:45-52.
28. Centers for Disease Control and Prevention (CDC). Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR 2003;52:329-32.
29. Centers for Disease Control and Prevention (CDC). Voluntary HIV testing as part of routine medical care - Massachusetts, 2002. MMWR 2004;53:523-6.
30. Fernandez MI, Perrino T, Royal S, Ghany D, Bowen GS. To test or not to test: are Hispanic men at highest risk for HIV getting tested? AIDS Care 2002;14:375-84.
31. Houston S, Archibald CP, Strike C, Sutherland D. Factors associated with HIV testing among Canadians: results from a population-based survey. Int J STD AIDS 1998;9:341-6.
32. Lindan CP, Avins AL, Woods WJ, Hudes ES, Clark W, Hulley SB. Levels of HIV testing and low validity of self-reported test results among alcoholics and drug users. AIDS 1994;8:1149-55.
33. Davis WR, Deren S, Beardsley M, Wenston J, Tortu S. Gender differences and other factors associated with HIV testing in a national sample of active drug injectors. AIDS Educ Prev 1997;9:342-58.
34. Nyamathi AM, Stein JA, Swanson JM. Personal, cognitive, behavioral, and demographic predictors of HIV testing and STDs in homeless women. J Behav Med 2000;23:123-47.
35. Stein JA, Nyamathi A. Gender differences in behavioral and psychosocial predictors of HIV testing and return for test results in a high-risk population. AIDS Care 2000;12:343-56.
36. Phillips KA. Subjective knowledge of AIDS and use of HIV testing. Am J Public Health 1993;83:1460-2.